Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa
Publication
, Conference
Davison, J; Brassier, A; Broomfield, A; Chien, Y-H; Hahn, SH; Kronn, D; Kumada, S; Labarthe, F; Ohki, H; Pichard, S; Prakalapakorn, SG ...
Published in: Molecular Genetics and Metabolism
February 2021
Duke Scholars
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2021
Volume
132
Issue
2
Start / End Page
S31 / S32
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Davison, J., Brassier, A., Broomfield, A., Chien, Y.-H., Hahn, S. H., Kronn, D., … Meng, X. (2021). Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa. In Molecular Genetics and Metabolism (Vol. 132, pp. S31–S32). Elsevier BV. https://doi.org/10.1016/j.ymgme.2020.12.058
Davison, James, Anaïs Brassier, Alexander Broomfield, Yin-Hsiu Chien, Si Houn Hahn, David Kronn, Satoko Kumada, et al. “Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa.” In Molecular Genetics and Metabolism, 132:S31–32. Elsevier BV, 2021. https://doi.org/10.1016/j.ymgme.2020.12.058.
Davison J, Brassier A, Broomfield A, Chien Y-H, Hahn SH, Kronn D, et al. Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa. In: Molecular Genetics and Metabolism. Elsevier BV; 2021. p. S31–2.
Davison, James, et al. “Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa.” Molecular Genetics and Metabolism, vol. 132, no. 2, Elsevier BV, 2021, pp. S31–32. Crossref, doi:10.1016/j.ymgme.2020.12.058.
Davison J, Brassier A, Broomfield A, Chien Y-H, Hahn SH, Kronn D, Kumada S, Labarthe F, Ohki H, Pichard S, Prakalapakorn SG, Haack KA, Johnson J, Meng X. Mini-COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease (IOPD) who were previously treated with alglucosidase alfa. Molecular Genetics and Metabolism. Elsevier BV; 2021. p. S31–S32.
Published In
Molecular Genetics and Metabolism
DOI
ISSN
1096-7192
Publication Date
February 2021
Volume
132
Issue
2
Start / End Page
S31 / S32
Publisher
Elsevier BV
Related Subject Headings
- Genetics & Heredity
- 3202 Clinical sciences
- 3105 Genetics
- 1103 Clinical Sciences